Skip to main content

Table 3 Median total PCI scores and PCI scores for small bowel (region 9–12) from surgery, MRI and PET/MRI, patients grouped by surgical outcome and first treatment

From: Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study

 

Total PCI Surgical

(median, IQR)

Total PCI

MRI

(median, IQR)

pa

Total PCI PET/MRI

(median, IQR)

pa

PCI Small bowel Surgical

(median, IQR)

PCI Small bowel MRI

(median, IQR)

pa

PCI Small bowel PET/MRI

(median, IQR)

pa

All patients n = 34

24.5 (11.7–29.0)

20.0 (8.7–28.0)

0.007

21.5 (13.0–30.0)

0.6

3.5 (1.0–6.0)

4.0 (0.0–8.0)

0.531

5.5 (2.0–9.0)

0.001

Primary surgery (n = 24)

27 (13.5–31-5)

23 (8.5–28.0)

0.001

27.7 (12.0–30.8)

0.3

4.0 (1.3–6.0)

4.0 (0.0–8.0)

1.0

6.0 (2.3–9.0)

0.002

NACT (n = 10)

15.5 (11.0–24.3)

14.0 (8.8–25.8)

0.959

14.5 (13.0–23.3)

0.5

2.5 (1.0–5.0)

4.0 (0.0–7.59

0.26

4.5 (1.5–6.5)

0.139

No macroscopic residual tumor

n = 30

22.0 (11.0–28.0)

18.5 (7.7–27.2)

0.031

18.0 (12.5–28..0)

0.8

3.0 (1.0–5.0)

4.0 (0.0–8.0)

0.074

5.0 (2.0–7.0)

0.002

Macroscopic residual tumor (inoperable)

n = 4

36.0 (33.8–36.8)

28.5 (15.8–33.8)

0.066

34.5 (29.5–38.8)

0.5

9.5 (7.5–11.5)

3.5 (0.0–8.5)

0.068

10.0 (9.0–11.8)

0.2

  1. a In comparison with surgical PCI, Wilcoxon signed rank test. IQR interquartile range